Tue, May 18, 2021

Jay Olson Maintained (BIIB) at Buy with Increased Target to $325 on, May 18th, 2021

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-increased-target-to-325-on-may-18th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Jay Olson of Oppenheimer, Maintained "Biogen Inc." (BIIB) at Buy with Increased Target from $300 to $325 on, May 18th, 2021.

Jay has made no other calls on BIIB in the last 4 months.



There are 6 other peers that have a rating on BIIB. Out of the 6 peers that are also analyzing BIIB, 2 agree with Jay's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Laura Chico of "Wedbush" Maintained at Hold with Increased Target to $245 on, Monday, April 12th, 2021
  • Alethia Young of "Cantor Fitzgerald" Maintained at Hold with Decreased Target to $268 on, Wednesday, February 17th, 2021


These are the ratings of the 4 analyists that currently disagree with Jay


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $343 on, Monday, April 19th, 2021
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $305 on, Thursday, February 4th, 2021
  • Evan Seigerman of "Credit Suisse" Maintained at Buy with Decreased Target to $338 on, Thursday, February 4th, 2021
  • Marc Goodman of "SVB Leerink" Maintained at Buy with Decreased Target to $380 on, Thursday, February 4th, 2021